Mizuho Lowers Price Target on Apellis Pharmaceuticals (APLS) Amid Ongoing Eye Disease Therapy Challenges
Mizuho Lowers Price Target on Apellis Pharmaceuticals (APLS) Amid Ongoing Eye Disease Therapy Challenges Sheryar Siddiq Tue, November 25, 2025 at 9:39 PM GMT+8 1 min read In this article: APLS +0.45% ...